STUDY

Lamisil cured 67% of toenail fungus, vs 21–32% on Diflucan

“Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.” Salo H, Pekurinen M. PharmacoEconomics. 2002

Salo H, Pekurinen M · PharmacoEconomics · 2002

Economic analysis of a randomized trial
The finding

At 60 weeks, 67% had a complete clinical cure with terbinafine, versus 21% or 32% with the two fluconazole regimens.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Economic analysis using a blinded randomized trial. The study compared treatment costs per clinically cured nail using data from three treatment groups.
At a glance

Who was studied and for how long

People
137
Across three treatment groups
Treatment
12 or 24 weeks
Depending on regimen
Outcome
Week 60
Complete clinical cure of the target nail
What they did

How the study worked

137 peopletoenail fungusRANDOMSPLITTerbinafine48 people · 12 weeksFluconazole45 people · 12 weeksFluconazole44 people · 24 weeksMEASURED ATWeek 60target nail cure137 peopletoenail fungusRANDOMSPLITTerbinafine48 people · 12 weeksFluconazole45 people · 12 weeksFluconazole44 people · 24 weeksMEASURED ATWeek 60target nail cure
Use trial dataThe original trial enrolled people with toenail fungus confirmed by culture.
Compare regimensParticipants received 250 mg terbinafine daily for 12 weeks or 150 mg fluconazole weekly for 12 or 24 weeks.
Estimate cost per cureThe analysis used the cure rates at week 60.
What they found

The results

TerbinafineFluconazoleFluconazole

Complete clinical cure at week 60

The outcome was whether the target toenail appeared completely clear of disease.

Terbinafine 12 weeks
67%
Fluconazole 12 weeks
21%
Fluconazole 24 weeks
32%

Cost per cure

Terbinafine had a lower estimated cost per cure in the analysis, using Finnish prices at the time.

These percentages describe the tested dose schedules. The costs are historical and are not a guide to what patients pay today.
How much to trust it

Strengths and limits

Strengths

  • Used a randomized double-blind trial
  • Culture-confirmed dermatophyte infection
  • Followed patients to week 60

Limits

  • Tested two specific fluconazole schedules
  • Economic estimates used historical Finnish prices
  • The outcome was the target toenail
Moderate confidence. The clinical data came from a blinded comparison, but the cost calculation is specific to the time and setting.
What it means for you

The takeaway

More target nails cleared

Terbinafine had the higher complete clinical cure rate in this comparison.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

Onychomycosis

Fungal infection of a nail.

Clinical cure

The target nail appeared clear on examination.

Original source

Salo H, Pekurinen M. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.. Pharmacoeconomics. 2002;20(5):319-24.

PMID 11994041